One year lat­er, US Trade Rep­re­sen­ta­tive still sup­ports an IP waiv­er for Covid-19 vac­cines

It’s been al­most one year since the Biden ad­min­is­tra­tion first de­clared its con­tro­ver­sial sup­port for waiv­ing IP pro­tec­tions for Covid-19 vac­cines at the World Trade Or­ga­ni­za­tion, and there’s been lit­tle con­sen­sus on how and when that waiv­er might come to fruition.

De­spite the lack of progress, the Of­fice of the US Trade Rep­re­sen­ta­tive on Wednes­day re­it­er­at­ed the ad­min­is­tra­tion’s sup­port for the waiv­er as part of its lat­est spe­cial re­port on IP pro­tec­tion and en­force­ment world­wide.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER